熱門資訊> 正文

Artelo Biosciences GAAP每股收益为3.97美元

2025-11-12 22:28

ARTELO BIOSCIENCES INC C/WTS 25/06/2024(TO PUR COM)(ARTLW) 0

Artelo Biosciences press release (ARTL): Q3 GAAP EPS of $3.97.
In September 2025, the Company completed a confidentially marketed public offering of common stock with gross proceeds of $3.0 million.

More on Artelo Biosciences

Artelo Biosciences prices $2 million public offering; shares down over 24%
Artelo Biosciences announces pricing of $3 million public offering
Seeking Alpha’s Quant Rating on Artelo Biosciences
Financial information for Artelo Biosciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。